ACW 0.00% 2.4¢ actinogen medical limited

11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis

  1. 43 Posts.
    lightbulb Created with Sketch. 49
    [email protected]

    Research paper published by the Actinogen team diving into the current literature on 11BHSD1 inhibition. They describe some potential future indications for Xanamem but nothing conclusive - the science is still quite unclear on this one unfortunately.


 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
2.4¢
Change
0.000(0.00%)
Mkt cap ! $65.08M
Open High Low Value Volume
2.4¢ 2.5¢ 2.1¢ $526.7K 22.84M

Buyers (Bids)

No. Vol. Price($)
5 431842 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 499979 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.